Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma

BACKGROUND: Anal squamous cell carcinoma (SCC) generally carries a favorable prognosis, as most tumors are highly sensitive to standard of care chemoradiation. However, outcomes are poor for the 20–30% of patients who are refractory to this approach, and many will require additional invasive procedu...

Descripción completa

Detalles Bibliográficos
Autores principales: Principe, Daniel R., Cataneo, Jose L., Timbers, Kaytlin E., Koch, Regina M., Valyi-Nagy, Klara, Mellgren, Anders, Rana, Ajay, Gantt, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229146/
https://www.ncbi.nlm.nih.gov/pubmed/35751111
http://dx.doi.org/10.1186/s12885-022-09742-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229146/
https://www.ncbi.nlm.nih.gov/pubmed/35751111
http://dx.doi.org/10.1186/s12885-022-09742-7

Ejemplares similares